Jessica Fung
Stock Analyst at JP Morgan
(1.30)
# 3,377
Out of 4,736 analysts
8
Total ratings
50%
Success rate
-2.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Fung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Neutral | $150 → $170 | $264.99 | -35.85% | 2 | Feb 1, 2024 | |
| UTHR United Therapeutics | Maintains: Overweight | $290 → $294 | $367.97 | -20.10% | 2 | Nov 2, 2023 | |
| FSM Fortuna Mining | Upgrades: Outperform | n/a | $4.30 | - | 4 | Mar 31, 2017 |
Alnylam Pharmaceuticals
Feb 1, 2024
Maintains: Neutral
Price Target: $150 → $170
Current: $264.99
Upside: -35.85%
United Therapeutics
Nov 2, 2023
Maintains: Overweight
Price Target: $290 → $294
Current: $367.97
Upside: -20.10%
Fortuna Mining
Mar 31, 2017
Upgrades: Outperform
Price Target: n/a
Current: $4.30
Upside: -